Tag: drug development

A BSI study shows 90% of pharma manufacturers expect climate-driven supply chain interruptions to grow. Net-zero goals are now seen as corporate resilience and

Liverpool launches a £20m lab for disease drug discovery using robotics and AI to accelerate vaccine development and disease research.

FDA approves pacritinib (Vonjo), a new treatment for myelofibrosis in adults with low platelet counts, targeting abnormal bone marrow signaling.

FDA approves Carvykti, a groundbreaking CAR-T therapy for relapsed/refractory multiple myeloma, offering personalized immune-cell treatment for blood cancer pat

Manage CDK4/6 side effects in advanced breast cancer with clear guidance for each FDA‑approved drug, helping patients reduce symptoms and stay on therapy.

The FDA has approved the first new essential thrombocythemia drug in 30 years. Learn how Besremi works and offers a fresh treatment option for patients.

Clinical trial PROTEUS shows adding apalutamide to hormone therapy before surgery reduces recurrence risk in high-risk prostate cancer patients.

The FDA approved Sarclisa subcutaneous delivery for multiple myeloma patients, offering a wearable device option instead of traditional IV infusions for easier

Wine and alcohol may trigger mast cell reactions in mastocytosis patients, raising safety concerns and requiring careful management.

Find the best HGH suppliers by comparing product quality, pricing, and customer support. Read our detailed analysis of top HGH providers today.